Combination of IL-33 with PD-1 Blockade Augment Milc2s-Mediated Anti-Tumor Immunity.
CANCER IMMUNOLOGY IMMUNOTHERAPY（2024）
关键词
Group 2 innate lymphoid cells,Interleukin-33,Cancer immunotherapy,Mature ILC2,Programmed cell death protein-1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要